Optimising Long-Term Benefit of MS Treatment Archives - Medical Conferences

Home > ECTRIMS 2019 > Optimising Long-Term Benefit of MS Treatment

Featured articles

Late-breaking: Ofatumumab versus teriflunomide in relapsing MS

Trial

Phase 3, ASCLEPIOS

Conference

ECTRIMS 2019

8 November, 2019 12:08

Online First